Home/ Supplements/ Garlic/ CapriPlus

CapriPlus

product on market Tablet or Pill Karuna Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 25% of ingredients have research evidence
B Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Garlic and oil of oregano possess antimicrobial properties, while caprylic and sorbic acids are typically used as preservatives or antifungal agents. Research evidence for these ingredients in this specific combination is limited. The profile maintains a high safety score with no significant concerns noted.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for CapriPlus
Open Full PDF View on NIH DSLD →
Details

Label Data

4 Tablet(s)
Serving Size
30
Servings
Other Combinations
Product Type
25%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

1200 mg
Market median: 500.0mg (497 products) 135 studies (A:0, B:40)
Caprylic Acid
600 mg
Sorbic Acid
600 mg
Market median: 150.0mg (41 products)

Other Ingredients

Vegetable Stearine Stearate Silicon Dioxide Croscarmellose Sodium Ditab
Claims

Label Claims — Verification

Unverified All Other
Info

Product Information

Directions for Use

Suggested use for adults: Four tablets divided over one day, taken on an empty stomach, or as directed by your health care practitioner.

Formulation Notes

Caprylic acid, garlic and oil of oregano

This product contains no yeast, wheat, soy, corn, milk, sugar, artificial coloring, preservatives or flavoring.

This product is intended for professional use and is manufactured under strict quality control to ensure the optimum in purity, potency and reliability.

Additional Information

Keep in a cool, dry place, tightly capped.

Metadata

Product Details

UPC / SKU0 18647 09105 3
DSLD Entry Date2023-11-22
Product TypeOther Combinations
FormTablet or Pill
BrandKaruna
DSLD ID299261
Data Updated2026-04-11
Research

Research Evidence

142
Research Sources
53
Avg Quality
70
Meta Analysis
56
Systematic Review
12
Rct
2
Regulatory Source
1
Openfda Safety
B Garlic for the prevention of cardiovascular morbidity and mortality in hypertensive patients
Systematic Review The Cochrane database of systematic reviews 2012 PubMed DOI
B Garlic supplementation for the treatment of chronic liver disease: a meta-analysis of randomized controlled trials
Meta Analysis African health sciences 2023 PubMed DOI
B Consumption of large amounts of Allium vegetables reduces risk for gastric cancer in a meta-analysis
Meta Analysis Gastroenterology 2011 PubMed DOI
B Garlic for the common cold
Systematic Review The Cochrane database of systematic reviews 2014 PubMed DOI
B Effects of Garlic Supplementation on Cardiovascular Risk Factors in Adults: A Comprehensive Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials
Meta Analysis Nutrition reviews 2026 PubMed DOI
B Effects of seasoning on the formation of heterocyclic amines and polycyclic aromatic hydrocarbons in meats: A meta-analysis
Meta Analysis Comprehensive reviews in food science and food safety 2021 PubMed DOI
B A Systematic Review and Meta-Analysis of Ayurvedic Herbal Preparations for Hypercholesterolemia
Meta Analysis Medicina (Kaunas, Lithuania) 2021 PubMed DOI
B Garlic: A systematic review of the effects on cardiovascular diseases
Systematic Review Critical reviews in food science and nutrition 2023 PubMed DOI
B Garlic intake lowers fasting blood glucose: meta-analysis of randomized controlled trials
Meta Analysis Asia Pacific journal of clinical nutrition 2015 PubMed DOI
B Garlic for the common cold
Systematic Review The Cochrane database of systematic reviews 2012 PubMed DOI
View all evidence for Garlic →
Compare

Similar Products

View all Garlic products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.